BeStock  

Teva Pharmaceutical Industries TEVA

US equityMarket cap rank #452Infectious DiseaseCannabis & Hemp
$39.23 +$0.69 (+1.79%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $39.23 0.00%
Open$38.46
Prev close$38.54
Day range$38.30 – $39.91
Volume6.81M
Market cap$45.77B
P/E (TTM)91.2
Dividend yield–

TEVA Stock News

Headlines matching Teva Pharmaceutical Industries or the TEVA ticker, most recent first.

  • Leerink Partners Initiates Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Announces Target Price $45Market news · 9 Sep 2026 · Direct mention
  • UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $48 PositiveMarket news · 4 Sep 2026 · Direct mention
  • Goldman Sachs Initiates Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Announces Target Price $50Market news · 3 Sep 2026 · Direct mention
  • Jefferies Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $40Market news · 3 Sep 2026 · Direct mention
  • Evercore Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy RatingMarket news · 3 Sep 2026 · Direct mention
  • Scotiabank Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $40Market news · 3 Sep 2026 · Direct mention
  • J.P. Morgan Sticks to Their Buy Rating for Teva (TEVA)TipRanks · 25 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy RatingMarket news · 25 Sep 2026 · Direct mention
  • BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $43 PositiveMarket news · 24 Sep 2026 · Direct mention
  • Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 A.m. ETGlobeNewswire · 24 Sep 2026 · Direct mention
  • Teva Pharmaceutical Industries(TEVA.US) Director Sells US$14.36 Million in Common StockMarket news · 23 Sep 2026 · Direct mention
  • Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia CareGlobeNewswire · 16 Sep 2026 · Direct mention
  • UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $42Market news · 7 Aug 2026 · Direct mention
  • Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $44Market news · 27 Aug 2026 · Direct mention
  • Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $42 PositiveMarket news · 12 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TEVA.

Sign in to join the discussion.

Scroll to Top